- Previous Close
220.24 - Open
221.67 - Bid 189.52 x 800
- Ask 225.73 x 800
- Day's Range
219.88 - 225.49 - 52 Week Range
191.97 - 238.47 - Volume
450,267 - Avg. Volume
551,634 - Market Cap (intraday)
18.648B - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
41.36 - EPS (TTM)
5.37 - Earnings Date Oct 24, 2024
- Forward Dividend & Yield 2.88 (1.30%)
- Ex-Dividend Date Aug 29, 2024
- 1y Target Est
256.29
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
www.labcorp.com67,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: LH
View MorePerformance Overview: LH
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LH
View MoreValuation Measures
Market Cap
18.65B
Enterprise Value
24.36B
Trailing P/E
41.28
Forward P/E
13.93
PEG Ratio (5yr expected)
1.22
Price/Sales (ttm)
1.52
Price/Book (mrq)
2.33
Enterprise Value/Revenue
1.95
Enterprise Value/EBITDA
16.75
Financial Highlights
Profitability and Income Statement
Profit Margin
3.60%
Return on Assets (ttm)
4.08%
Return on Equity (ttm)
5.36%
Revenue (ttm)
12.49B
Net Income Avi to Common (ttm)
449.5M
Diluted EPS (ttm)
5.37
Balance Sheet and Cash Flow
Total Cash (mrq)
265.1M
Total Debt/Equity (mrq)
75.49%
Levered Free Cash Flow (ttm)
801.65M
Research Analysis: LH
View MoreCompany Insights: LH
LH does not have Company Insights
Research Reports: LH
View MoreRaising price target to $260
LabCorp operates one of the largest global clinical laboratory networks, managing more than 160 million patient encounters each year, or more than 3 million patient specimens per week. LabCorp businesses also support clinical trial activity in approximately 100 countries. LabCorp has a market cap of about $18 billion. The company is a component of the S&P 500.
RatingPrice TargetU.S. stock indices are mostly in the red today, with investors perhaps
U.S. stock indices are mostly in the red today, with investors perhaps experiencing a little 'green exhaustion' after the solid gains booked of late. Also of note, the meaningful news starts to hit the tape tomorrow with the release of the Fed minutes, so getting a little defensive in case the minutes include unwanted news is also defensible.
Daily – Vickers Top Buyers & Sellers for 08/08/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Labcorp Earnings: Solid Medical Utilization Contributes to Healthy Volume Gains
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
RatingPrice Target